PCBAIR Unveils 8-Layer Glass Core PCB Manufacturing for Next-Gen AI & HPC
SHENZHEN, China, Dec. 8, 2025 /PRNewswire/ -- PCBAIR announced the launch of its advanced 8-layer Glass Core PCB manufacturing capabilities, combining proprietary Through Glass Via (TGV) technology with multi-layer redistribution layers (RDL). The...
SANY and Pony.ai Announce Mass-Production Readiness of Fourth-Generation Autonomous Heavy-Duty Truck
BEIJING, Dec. 8, 2025 /PRNewswire/ -- SANY Group announced that the fourth-generation autonomous heavy-duty truck co-developed by SANY Heavy Truck and Pony.ai is nearing mass-production readiness, with the first batch set for commercial operation...
Goodix Powers Samsung's Galaxy Z TriFold with Advanced Foldable Touch and Fingerprint Solutions
SHENZHEN, China, Dec. 8, 2025 /PRNewswire/ -- Goodix Technology today announced that its industry‑leading main & sub touchscreen controller and ultra‑narrow side‑key capacitive fingerprint solution are featured in Samsung's first multi-folding...
GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'
- First anthrax vaccine developed using recombinant DNA technology - Annual production capacity of up to 10 million doses at GC Biopharma's facility YONGIN, South Korea, Dec. 8, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a leading global...
Median PFS Trending Beyond One Year: Leads Biolabs' LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
NANJING, China, Dec. 8, 2025 /PRNewswire/ -- From December 6 to 9, 2025, the 67th Annual Meeting of the American Society of Hematology ("ASH") was held in Orlando, Florida, USA. Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company",...
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 8, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product...
AV‑Comparatives triumphs at 2025 "Tiroler Innovationspreis 2025"
INNSBRUCK, Austria, Dec. 6, 2025 /PRNewswire/ -- The independent cybersecurity testing authority AV‑Comparatives has been awarded the top honor in the "Technical Innovation" category at the 2025 "Tiroler Innovationspreis" (Tyrolean innovation...
China Automotive Systems Advances High-Torque Intelligent Steering Motors to Mass Production for Commercial Vehicles
WUHAN, China, Dec. 5, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that its subsidiary, Hyoseong (Wuhan) Motion...
Prof. Gang Shen's Research Paper about Mandibular Advancement Repositioning Technology in the Journal of Aligner Orthodontics
SHANGHAI, Dec. 5, 2025 /PRNewswire/ -- A clinical study developed by Professor Gang Shen's Orthodontic Team from Taikang Bybo Dental has been officially published in the Journal of Aligner Orthodontics (JAO). The article presents key findings on the...
NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO
Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread resistance The Phase 1 ragistomig study achieved its...